ARTICLE | Clinical News
Fycompa perampanel regulatory update
March 11, 2013 7:00 AM UTC
Germany's Federal Joint Committee (G-BA) issued final benefit assessments for epilepsy drug Fycompa perampanel from Eisai saying that Fycompa has no additional benefit over comparators to treat partia...